Ann-Marie Broome to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Ann-Marie Broome has written about Xenograft Model Antitumor Assays.
Connection Strength
0.205
-
Dual Receptor-Targeted Theranostic Nanoparticles for Localized Delivery and Activation of Photodynamic Therapy Drug in Glioblastomas. Mol Pharm. 2015 Sep 08; 12(9):3250-60.
Score: 0.118
-
Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo. Ann Surg Oncol. 2019 Dec; 26(13):4782-4790.
Score: 0.039
-
Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablation. Pharm Res. 2014 Jun; 31(6):1407-17.
Score: 0.026
-
Deep penetration of a PDT drug into tumors by noncovalent drug-gold nanoparticle conjugates. J Am Chem Soc. 2011 Mar 02; 133(8):2583-91.
Score: 0.022